Navigating nutraceuticals regulation: A comparative assessment of the USA and India

What are nutraceuticals, Exactly?

Dr Stephen DeFelice first used the phrase “nutraceuticals” in 1989.^1–7 It means “food or a portion of a food that provides medical or health benefits, including the prevention and/or treatment of a disease. ¹ ” Even though this definition might be correct, no regulatory body in any nation now recognizes it.

An optimally nutritionally balanced body has been disrupted by foods and eating habits in today’s lifestyle. As a result, it would be great to be in a condition of good health where “food be your medicine.” The nutraceutical market is growing rapidly.

Worldwide, and without a precise regulatory definition, nutraceutical rules are constantly changing. In many nations, nutraceuticals are regulated as food supplements rather than pharmaceuticals due to this ambiguity. These products are commonly believed to be “safe” and to have fewer negative effects.

Countries differ greatly in how they employ nutraceuticals; some may just use them for general health and well-being, while others allow them for medical use. ⁵ Food supplements are taken in many nations to supplement the regular diet and guarantee that certain nutrients (such as vitamins and minerals) are consumed in the right amounts. ³ A lot of doctors and customers look for nutraceutical products since various medical disorders lead to special nutritional needs and the necessity to take nutrients in unconventional ways.

This article provides a brief overview of the rules governing nutraceuticals set forth by the US Food and Drug Administration and the Food Safety Standard Authority of India. It mainly focuses on the similarities and differences between the regulatory framework and structure for nutraceuticals in the USA and India, with similar technical requirements for the registration of nutraceutical goods in this market. This article is based on the full set of legal requirements that nations that want to register a nutraceutical food or pharmaceutical product must meet.

Classification of nutraceuticals

There are many methods to classify nutritional supplements, including by their source, purpose, and mechanism of action (Figure 1).^8–10 Here are some typical categories for nutraceuticals:

OPEN IN VIEWER

Figure 1.

Classification of nutraceuticals. ⁹

The benefits & needs of nutraceuticals

Nutraceuticals products are used in various disease to prevent and cure the disease.^11–26

Nutraceuticals products majorly used in following disease and condition.

(a) Nutraceuticals against Alzheimer’s disease (AD)

According to the Department of Biotechnology, Ministry of Science & Technology, Government of India, India has the highest rate of diabetes in the world for a developing country. Diabetes affects about 77 million individuals, and by 2045, that figure is expected to rise to 134 million. One-fourth of all deaths from cardiovascular disease are caused by diabetes. Hypertension is another serious problem. The National Health Policy (NHP) of our country aims to reduce premature mortality and noncommunicable diseases by up to one-third by 2030.

Healthcare professionals now treat chronic patients who are malnourished. It is brought on by poor eating habits, insufficient food intake, and malnutrition. Each of these elements is essential to the development and diagnosis of chronic illnesses. Nutraceuticals are regarded as beneficial resources for fostering well-being and averting serious conditions like diabetes and GIT disorders. Kidney and infections to deliver high-quality medical facilities while lowering healthcare costs.

Nutraceuticals and functional foods are crucial for preventing and treating diseases and symptoms associated with lifestyle changes.

Marine components provide omega-3 fatty acids, and most clinical studies have shown the benefits of a range of nutraceuticals, including phytochemicals and dietary extracts that help lower inflammation and oxidation.

Key regulatory authorities

In India, nutraceuticals are regulated by the Food Safety and Standards Authority of India (FSSAI) and the Central Drugs Standard Control Organization (CDSCO).

Requirements for registration and regulation of nutraceuticals

A manufacturer cannot begin operations until they are properly registered or licensed^37–40; The safety officer has inspected the premises following the issuance of an ID number in accordance with the FSSAI act.

The license granted in accordance with these rules must remain in effect and be in operation for a duration of 15 years, unless otherwise specified.

Manufacturers who have a turnover of more than 12 months must receive a valid license from the FSSAI office, and they must register with the state office commissioner. This also applies to small-scale food producers.

An application for a license grant must be made. An application in form B of schedule 2 must be filled out in order to receive a license. After the application ID number is issued, the license will also be awarded within 60 days.

The FSSAI provides a number of steps that must be followed in order to register as a nutraceutical in India.

To put their goods on the market, they must fill out and get authorized a number of forms, including FORM A and FORM B. The process chart to obtain approval is as follows:

FSS regulations, 2011, frames that:

(a) For the registration form A/B has to be filled for the manufacturing in india according to sch-1

Following documents are needed for the approval:

(1) Form A

Enclosed with the new license or import license application to the State or Central Licensing Authority are the necessary documents.

(1) Form-A, Form-B, Form-C

(Figure 3).

OPEN IN VIEWER

Figure 3.

Registration process of nutraceutical in India. ⁴⁰

Labelling requirements and claim

Act of 1994 on Dietary Supplement Health Education (DSHEA)

This statute, which was presented in the Senate by Senator Orrin G. Hatch, defines dietary supplements and lays out the legal conditions for their promotion in the United States. ⁴⁰

According to the law, a product that includes one or more of the following dietary elements is considered a dietary supplement:

Vitamin, mineral, herb, or other botanical; amino acid; vitamin; dietary substance intended for human consumption to augment the diet by raising the overall dietary intake of that component; and a constituent, extract, metabolite, concentration, or any combination of these.

The DSHEA further stipulates that goods used for oral administration must be dietary supplements. Dietary supplements come in a variety of forms, including extracts and concentrates.

Tablets, capsules, soft gels, gel caps, liquids, and powders “DS” do not require USFDA approval prior to marketing. However, the FDA has evaluated safety efficacy, and appropriate labelling provisions ensure that this is not intended to diagnose or treat any illness. The high price of medications, such as allopathic drugs, led to the development of nutraceuticals and an expansion of the worldwide market.

Registration of dietary supplements in U.S.A

Dietary supplements are covered by 21 CFR 190; in order to register a dietary supplement in the United States, its contents must be divided into two categories: active and inactive. ⁴⁰ The product should contain an active component that satisfies the DSHEA, 1994 definition.It can be recognized as a dietary ingredient if it satisfies the requirements.

For legal registration purposes, the dietary ingredient is separated into two categories. “Grandfathered” or “Old Dietary Ingredient” (ODI) refers to a product that was introduced to the market on or before October 15, 1994. By verifying its safety signal, these items are permitted to remain on the market.

New Dietary Ingredients (NDIs) are defined as goods that are introduced to the market after October 15, 1994, or after the ODI was modified. To put the aforementioned items on the US market, the company must obtain FDA premarket clearance. The organization in charge of this procedure for the NDI is the Centre for Food Safety and Applied Nutrition (CFSAN).

For the NDI to receive pre-market clearance, the necessary paperwork must be sent to the CFSAN at the following address:

Office of Nutritional Products, Labelling and Dietary Supplements (HFS-820), Center for Food Safety and Applied Nutrition, Food and Drug Administration, 5100 Paint Branch Pkwy, College Park, MD 20740.

The following documents are needed:

The applicant’s full name and address

The product’s name (including any binomial names if it’s a plant or herb)

The product description, which says:

(i) Product NDI Level

Safety Evidence (such as published articles for NDI or usage history in the event of a modified ODI).

The signature of the concerned authorities on the dietary supplement’s manufacturer or distributor.

The Clearance Regulatory Process

The maker or distributor is responsible for claiming the product’s safety by providing the necessary documentation. The FDA does not approve dietary supplements like it does other medication products.

The GMP guidelines for dietary supplements were published by the USFDA and are applicable to both domestic and international businesses. The criteria for the manufacture, packaging, labeling, and holding of nutritional supplements are outlined in this GMP rule (Figures 4 and 5).

OPEN IN VIEWER

Figure 4.

Registration process in USA.^39,40

OPEN IN VIEWER

Figure 5.

Registration process for the Clearance.^39,40

Labelling requirements and claim

USA labelling requirements

Many enquiries concerning the labelling of dietary supplements are sent to the Food and Drug Administration (FDA).^54–56 The activity in this field over the last few years has led to these enquiries.

Using a “question and answer” format, the USFDA has listed the most commonly asked questions on the labelling of dietary supplements.

In order to ensure that dietary supplements sold in the United States (U.S.) are appropriately labelled, the USFDA has created this guide. To import or distribute a dietary supplement, our policies do not require label clearance.

Before putting their products on the market, nutraceutical makers must also make sure they are safe. If any dangerous products are released onto the market, the FDA is empowered to take action.

In the US, the FDA oversees the regulations and standards pertaining to nutraceuticals. The FDA carries out the rules and regulations that the DSHEA established.

The US-FDA’s main standards for nutraceutical labelling are as follows:

(1) The label ought to include the term “dietary supplement.”

(2) The quantity of each component per serving should be listed.

(3) Any claims ought to be noted on the label.

(4) The label should include information on allergens, cautions, and safety measures.

(5) The label needs to include the date of manufacturing and expiration.

(6) Only English should be used to prepare the label.

(7) The label should include the manufacturer’s name and address.

Nutraceutical goods in the US have to adhere to the Food and Drug Administration’s (FDA) labelling regulations.

There must be five statements:

(1) The brand name and common name of the product serve as the assertion of identity. The phrase “dietary supplement” must appear on the label of any dietary supplement.

(2) The dietary supplement’s net quantity of contents statement, which includes the product’s overall weight or volume, the macro- and micronutrients, the suggested serving size, and any added sugar.

(3) The product’s nutrition label: Details regarding any allergies.

(4) The list of ingredients: The quantity of components in a serving size of supplements

(5) The manufacturer, packer, or distributor’s name and address.

Dates of use or best by: The product’s recommended consumption dates (Figure 6).

OPEN IN VIEWER

Figure 6.

Reference label of product Ref. 56.

The major display panel, or PDP, is the area of the label that the customer is most likely to see.

The panel of the box (or bottle) is most likely to be shown, presented, shown, or examined in accordance with standard conditions of display for retail sale. Included in the PDP must be the following information:

(1) The Identifying Statement

(2) Net Quantity and Contents (must be shown separately)

The net quantity must appear inside the bottom 30% of the PDP in lines parallel to the container’s resting base and be accurately expressed in both the US Customary system and the metric system, unless the PDP size is less than five square inches.

The IP, or information panel

It is identified by the panel of the box (or bottle) directly to the PDP’s right. Without any non-essential information in between, the IP must have the following required information:

(1) The Additional Information

(2) The Ingredient List, which is arranged by weight in descending order of predominance using the common name

(3) Serious Allergens in Food

(4) Contact Details, such as Manufacturer’s Name and Business Address (or Packer or Distributor)

(5) If the product is imported, the country of origin

(6) Other details that, while occasionally required, usually do not have particular restrictions on placement include:

Safe use instructions, product warnings and cautions, the FDA structure function claim disclaimer, the company phone number for reporting adverse events, storage instructions, the lot number, and the best by date.

Note: If the panel next to your PDP is at the top of the container and it has no other PDPs, it must be utilised as IP. The IP is the panel to the right of the PDP if there are other PDPs (Figure 7).

OPEN IN VIEWER

Figure 7.

Reference Label of product. ⁵⁶

Information placement

The necessary label statements must be displayed on the label’s IP, PDP, or front panel in type sizes of at least 1/16” and with a 3:1 height-to-width ratio.

Your label must be free of any distracting vignettes or graphics, and the background colour must be sufficiently different from the font colour to make it readable.

Note: You must submit a petition to request an alternate labelling rule if your packaging isn’t big enough to fit a 1/16” type size.

Intervening material, such as unnecessary label information (like the UPC code), cannot be positioned between the IP’s mandatory label assertions.

Labelling of Nutrition

A nutritional label or supplement information panel lists the names and amounts of the *dietary elements in your supplement in “servings” and “servings per container.”

*Dietary elements are substances that contribute to the overall amount of food consumed by humans.

Declaration of nutrients

Nutrients that must be listed on the Supplementary Facts panel in quantifiable amounts include total calories, calories from fat, total fat, saturated fat, cholesterol, sodium, total carbohydrate, dietary fibre, sugars, protein, vitamin A, vitamin C, calcium, and iron.

If your product has claims concerning unsaturated fats, fibres, or carbohydrates, you also need to show the calories from these components.

(1) The supplement panel, with the caption “Supplement Facts,” must be enclosed in a box with *hairlines.

(2) Footnotes must have a minimum type size of six points, and the material inside the box must have a minimum type size of eight points.

(3) Every heading and title needs to be bolded.

Lack of International Consensus on definitions

A primary challenge in the nutraceutical industry is the lack of a universal definition for nutraceuticals. Various countries categorize these products differently as dietary supplements, functional foods, or therapeutic goods. This inconsistency creates varying regulatory standards, which further complicates global trade and compliance efforts.

Inconsistent Regulatory Frameworks

The nutraceutical regulatory approaches are quite different between the countries:

United States: Nutraceuticals are regarded as dietary supplements under the Dietary Supplement Health and Education Act of 1994. Prior to marketing, manufacturers must ensure product safety and accurate labeling. There is no requirement for pre-market approval. Once products are on the market, the FDA chiefly intervenes against products declared unsafe or misleading.

India: As per the Food Safety and Standards Act of 2006, nutraceuticals are included in the classification of “Foods for Special Dietary Uses.” The Food Safety and Standards Authority of India supervises its regulatory affairs by laying emphasis on ingredient safety, purpose of use, and the manner of production. Labeling compliances must be met in order to allow their sale in the market.

Differences in such rules create an impediment to those companies dealing in multiple countries due to differing rules and regulations.

Labeling and Health Claims

Labeling and health claims regulations differ:

United States: Structure-function claims are allowed without FDA approval, as long as they are truthful and not misleading. Health claims that imply disease prevention or treatment require FDA approval. The FTC can take enforcement action against misleading claims.

India: The FSSAI demands strict compliance with labeling standards. Goods that do not measure up to these standards are barred from market authorization.

Manufacturers find it difficult to meet the divergent labeling requirements.

Quality Control and GMP

Maintaining quality is integral to their product.

United States: GMP regulations are enforced by the FDA under 21 CFR Part 111. The regulations involve quality control measures, record-keeping, and testing of raw materials and finished products. Failure to comply will result in product recalls, fines, and even lawsuits.

India: The FSSAI has a GMP standard, which the companies have to comply with. Failure to comply results in product withdrawal and rejection.

GMP compliance is quite challenging for smaller manufacturers because they have limited resources.

Post-market Surveillance and Enforcement

Monitoring product safety after market entry is crucial:

United States: Manufacturers are required to create adverse event reporting systems to keep track of any consumer safety concerns. The FDA can take legal action against such non-compliant products.

India: The FSSAI is required to monitor the post-market surveillance, including tracking adverse events, and ensure the compliance with regulation. However, limited resources and infrastructure can deter effective enforcement.

Inadequate post-market surveillance can lead to the continued sale of unsafe or substandard products, which then pose risks to consumer health.

International cooperation must be sought in order to harmonize definitions and standards and, more importantly, to strengthen mechanisms of enforcement that ensure consumer safety and product efficacy.

Tighter health Claims and product safety Oversight

The regulatory authorities are now enforcing more stringent rules, ensuring that nutraceutical products do not make unsubstantiated health claims. This trend aims to protect consumers from misguided information and ensure product efficacy.

New Classifications of Supplements

The regulatory environment is responding by creating space for new categories of supplements aimed at addressing certain health needs. Examples include increasing the attention being focused on women’s health issues such as beyond just prenatal care support, to also include menopause and digestive health.

Personalized Nutrition

Regulators are recognizing the rise of personalized nutrition and are working to establish frameworks that ensure the safety and efficacy of customized nutraceutical products tailored to individual health profiles.

Adoption of Digital Transformation and Advanced Technologies

This involves the integration of digital tools and advanced technologies into regulatory affairs. Some examples include making use of data analytics in regards to product safety monitoring and introduction of electronic systems to make regulatory submissions and reviews quicker and easier.

Global Harmonization of Regulations

There is now a concerted move to harmonise nutraceutical regulations across all regions in facilitating international trade as well as keeping the standards on the products similar. This also includes aligning definitions, safety assessments, and labeling requirements.

All these trends characterize a dynamic environment of regulation and seek to make a balance in the imperative on consumer safety, informed choice with innovation in nutraceutical.